Moderna Loss on future firm purchase commitments remained flat by 0.0% to $5.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 75.0%, from $20.00M to $5.00M.
other_legal_contingency_future_firm_purchase_commitments| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $159.00M | $342.00M | $349.00M | $268.00M | $220.00M | $220.00M | $98.00M | $79.00M | $24.00M | $1.00M | $21.00M | $60.00M | $20.00M | $14.00M | $12.00M | $5.00M | $5.00M |
| QoQ Change | — | — | +115.1% | +2.0% | -23.2% | -17.9% | +0.0% | -55.5% | -19.4% | -69.6% | -95.8% | >999% | +185.7% | -66.7% | -30.0% | -14.3% | -58.3% | +0.0% |
| YoY Change | — | — | — | — | — | +38.4% | -35.7% | -71.9% | -70.5% | -89.1% | -99.5% | -78.6% | -24.1% | -16.7% | >999% | -42.9% | -91.7% | -75.0% |